Histamine H₃R antagonists: From scaffold hopping to clinical candidates

Neuroscience

• H3 Receptor Antagonist 100%
• Central Nervous System 66%
• Neuropathic Pain 66%
• Alzheimer's Disease 33%
• Parkinson's Disease 33%
• Diabetes Mellitus 33%
• Aspartic Acid 33%
• Norepinephrine 33%
• Serotonin 33%
• Acetylcholine 33%
• G Protein Coupled Receptor 33%
• Histamine H3 Receptor 33%
• Neurotransmitter Release 33%
• Attention Deficit Hyperactivity Disorder 33%
• Mood Disorder 33%
• Narcolepsy 33%
• Central Nervous System Disease 33%
• Obstructive Sleep Apnea 33%
• Sleep Disorder 33%
• Catalepsy 33%
• Tourette Syndrome 33%
• Dopamine 33%
• Epilepsy 33%
• Amine 33%
• Schizophrenia 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Histamine H3 Receptor Antagonist 100%
• Neuropathic Pain 66%
• Alzheimer's Disease 33%
• Diabetes Mellitus 33%
• Serotonin 33%
• Noradrenalin 33%
• Acetylcholine 33%
• Aspartic Acid 33%
• Neurotransmitter 33%
• G Protein Coupled Receptor 33%
• Histamine H3 Receptor 33%
• Parkinson's Disease 33%
• Central Nervous System Disease 33%
• Epilepsy 33%
• Attention Deficit Disorder 33%
• Mood Disorder 33%
• Sleep Disorder 33%
• Narcolepsy 33%
• Sleep Disordered Breathing 33%
• Catalepsy 33%
• Gilles De La Tourette Syndrome 33%
• Dopamine 33%
• Amine 33%
• Schizophrenia 33%

Keyphrases

• Depression/mood Disorder 50%
• Construction Pattern 50%